Mitsuru Naiki
Osaka, 5410046, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Assessment of Tie2-Rejuvenated Nucleus Pulposus Cell Transplants from Young and Old Patient Sources Demonstrates That Age Still Matters.
Journal: International journal of molecular sciences
Published: May 13, 2024
Neurotropin® ameliorates chronic pain associated with scar formation in a mouse model: A gene expression analysis of the inflammatory response.
Journal: Molecular pain
Published: March 21, 2024
Repurposing of the analgesic Neurotropin for MASLD/MASH treatment.
Journal: Hepatology communications
Published: February 06, 2024
Recombinant Laminin-511 Fragment (iMatrix-511) Coating Supports Maintenance of Human Nucleus Pulposus Progenitor Cells In Vitro.
Journal: International journal of molecular sciences
Published: October 13, 2023
Association of NAT2 genetic polymorphism with the efficacy of Neurotropin® for the enhancement of aggrecan gene expression in nucleus pulposus cells: a pilot study.
Journal: BMC medical genomics
Published: December 18, 2020
Neurotropin Inhibits Lipid Accumulation by Maintaining Mitochondrial Function in Hepatocytes via AMPK Activation.
Journal: Frontiers in physiology
Published: January 28, 2020
Stress enhances gait disturbance induced by lumbar disc degeneration in rat.
Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
Published: February 09, 2017
Neurotropin® inhibits calpain activity upregulated by specific alternation of rhythm in temperature in the mesencephalon of rats.
Journal: Life sciences
Published: September 20, 2016
Neurotropin attenuates local inflammatory response and inhibits demyelination induced by chronic constriction injury of the mouse sciatic nerve.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: January 06, 2016
Creatinine metabolite, HMH (5-hydroxy-1-methylhydantoin; NZ-419), modulates bradykinin-induced changes in vascular smooth muscle cells.
Journal: Journal of receptor and signal transduction research
Published: March 20, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026